FDA 483 - Alembic Pharmaceuticals Limited - November 10, 2021

No document content was provided for summarization. The input consisted solely of a list of page references (Page 1 of 25 through Page 25 of 25) without any textual information from an FDA 483 document. Therefore, it is not possible to identify the company name, inspection dates, main violations, regulatory framework, or required actions, nor can a concise summary within the 150-300 word limit be generated. To fulfill the request, please provide the complete text of the FDA 483 document.